Please login to the form below

Not currently logged in

Novartis' German poster campaign to raise vaccination awareness

In-house designed work aims to educate public about meningococcal bacteria

Novartis office 

Novartis has launched a German poster campaign to raise public about meningococcal bacteria and vaccinations.

Backed by the Berlin Centre for Travel and Tropical Medicine, the campaign's posters will be displayed in 350 Sanifair toilets in Tank & Rast GmbH Travelers service stations across the country.

The campaign was conceived in-house by Christian Wieszner and Björn Kapplinghaus, of Novartis Vaccines' Eastern Europe and Central Europe marketing divisions, and its organisers expect the posters to be seen by some 62 million people by the end of March.

Meningococcal bacteria can be transmitted through droplet infection when coughing, sneezing, or kissing. It is a particular risk when the immune system is weakened by other infections, allowing the bacteria to multiply, and potentially leading to meningitis and blood poisoning.

The company's meningococcal B vaccine, Bexsaro, won European approval last year and was launched in Germany in December.

The campaign is not the first time Novartis Vaccines has used motorway service areas as the backdrop and follows its 2009 motorway campaign educating the public about seasonal influenza.

A survey among travellers at that time showed that nearly half of the respondents could recall details of the poster. The survey found participants predominantly in favour of posters educating them about health risks.

Article by
Tara Craig

26th March 2014

From: Marketing



COVID-19 Updates and Daily News

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...